|Dr. Ehud Geller Ph.D.||Exec. Chairman & Acting CFO||N/A||N/A||N/A|
|Mr. Ilan Hadar M.B.A., MBA||Chief Exec. Officer||N/A||N/A||1969|
|Dr. David E. Weinstein||Pres & Chief Medical Officer||N/A||N/A||1958|
|Dr. Sigal Aviel||Chief Operating Officer||N/A||N/A||1964|
|Prof. Eli Hazum Ph.D.||CTO & Director||N/A||N/A||N/A|
|Dr. Stephen A. Cooper D.M.D Ph.D.||Exec. VP of Devel.||N/A||N/A||N/A|
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of products for the treatment of pain in Israel. It develops PRF-110, a product based on local anesthetic ropivacaine, which completed Phase II clinical study in hernia repair. The company was founded in 2007 and is headquartered in Herzeliya, Israel.
PainReform Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.